Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
about
T helper 17 cells promote cytotoxic T cell activation in tumor immunityTumor-specific Th17-polarized cells eradicate large established melanomaCigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways.Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo.IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent mannersThe roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model.Collision tumor of primary laryngeal mucosal melanoma and invasive squamous cell carcinoma with IL-17A and CD70 gene over-expression.An IL12-IL2-antibody fusion protein targeting Hodgkin's lymphoma cells potentiates activation of NK and T cells for an anti-tumor attack.Potentially functional polymorphism in IL-23 receptor and risk of acute myeloid leukemia in a Chinese populationPrimary mucosal melanoma arising from the eustachian tube with CTLA-4, IL-17A, IL-17C, and IL-17E upregulationDendritic cell-based vaccines: barriers and opportunitiesDendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccinationTh17 cells in cancer: help or hindrance?Cell-intrinsic role for IFN-α-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response.T(H)17 cells in tumour immunity and immunotherapy.Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 SignalingTGF-beta and tumors--an ill-fated alliance.Immunotherapy of cancer by IL-12-based cytokine combinationsEssentials of Th17 cell commitment and plasticityPersistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.Interleukin-17 and type 17 helper T cells in cancer management and research.Th17 cells: a new therapeutic target in inflammatory dermatoses.Adoptive immunotherapy of cancer using CD4(+) T cells.Ustekinumab in the therapy of chronic plaque psoriasis.IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activityAntimelanoma immunotherapy: clinical and preclinical applications of IL-12 family members.Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.Targeting two co-operating cytokines efficiently shapes immune responses.Assessing the development of murine plasmacytoid dendritic cells in Peyer's patches using adoptive transfer of hematopoietic progenitors.Cytokine-modified VSV is attenuated for neural pathology, but is both highly immunogenic and oncolytic.In support of descriptive studies; relevance to translational researchInflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.
P2860
Q24646584-7275D864-D636-4D26-B16B-BD59078D8D3BQ24648032-B480FD7E-1A4C-44FC-84E7-E92736121F57Q33642445-277482F2-AE6E-453C-9F7D-72C2A4EA079DQ33913506-CE832FEC-20D7-4A36-9C5E-86B26881B29CQ33929197-F451F804-3552-4622-88D6-0998F2455050Q33944262-CE7FD3E3-3476-49F1-B211-5F274ED5545FQ33945653-9C074958-CA49-43B4-8CF5-09A2FF0529CDQ33987288-77AB4EFE-C969-4670-B3BA-B9092BE123D9Q34376431-795B4864-D054-4151-8D8C-16CE54EAD3F8Q34427113-C328F6E4-43C7-4ED8-8D5B-F21E4B068607Q34580965-A86B67C2-9D1D-4B19-9678-8942F6B51255Q34647661-1D68E23C-0983-473C-BE8E-1C1272E26D8EQ34661797-00069F2F-A020-4815-83DA-F95EFC9D3CEFQ34759603-2096642B-11EA-4BBE-813D-52F3D8E899DDQ34913808-EC6F0E7D-98D1-499E-B5CC-4840259D2A42Q35346365-22F1654B-6B17-4C0B-B080-FCD9CEA8B8BDQ35623903-40D424EA-F260-404A-AC39-4B2E8CE8FCEAQ35674805-2D1D235B-6138-4ABB-9EAF-EFB107C16C98Q36020084-2CCE55E9-16BE-4E9E-AC4A-B0D748AE4D6EQ36724827-F50E65FE-24D4-4439-9B77-620A9A6FB7B8Q36730400-1CE3B156-DF0B-4C5C-A2DB-106B1519481EQ36745336-4FD9D118-EF9D-4151-A7FE-FE1AD687FDB6Q37031654-0C160FD1-F6B0-49AC-8A16-52BD0EE1B053Q37216488-EAB604FF-A0D9-4D56-A33F-6D316C9AB18BQ37275304-3FF85D8D-8532-45A9-AEA6-1603AAF2B71BQ37303190-48D51A45-C17D-49A8-931B-EAF9CB7BE7FCQ37413874-46C2E7E4-514E-47C0-9E32-C2678FD17FDDQ37793235-EA6FC92E-DD0D-4C9F-9E37-CA7FE94ECBB9Q38073096-54BDBBF8-1967-4B27-B0CC-DCE7DF5573B8Q39254820-BCA8B58C-931C-4D61-8A73-92B3F32420EAQ39920448-18A268D5-DA0C-44B7-83FE-A7701949A733Q40929510-35374739-2AD0-433A-B881-49DB4D5C2536Q41779828-F181B3A0-A5DB-4BC6-86CE-CF33989DD9C0Q41829468-59941E9F-87AB-40D5-84CB-6DBA0B53892AQ42786231-AD8AF89E-D19C-47A2-9F6B-8B9A89D91A41Q45756098-0466EA8C-95E3-429C-9592-A088EE9ADBC8Q46411431-D7FE411B-3A6B-4E92-AF3F-6793CB8621D8Q52746279-8A6E40B7-8EB8-458F-8BB5-CF3DC875B878
P2860
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
@ast
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
@en
type
label
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
@ast
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
@en
prefLabel
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
@ast
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
@en
P2093
P2860
P1476
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
@en
P2093
Ada M Kruisbeek
Anna M Keller
Bianca Blom
Felicia H Tirion
Jasper G van den Boorn
John B A G Haanen
Karin E de Visser
Laurina A de Jong
Marc R Theoret
Nicholas P Restifo
P2860
P304
P356
10.4049/JIMMUNOL.176.9.5213
P407
P577
2006-05-01T00:00:00Z